التفاصيل البيبلوغرافية
العنوان: |
Rituximab desensitization protocol in a child with secondary lymphoproliferative disease. |
المؤلفون: |
Aranda CS; Federal University, São Paulo, Brazil. Electronic address: carolaaranda@yahoo.com.br., Ensina LF; Federal University, São Paulo, Brazil., Mallozi MC; Federal University, São Paulo, Brazil., Filho VO; University of São Paulo, São Paulo, Brazil., Solé D; Federal University, São Paulo, Brazil. |
المصدر: |
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2019 Nov; Vol. 123 (5), pp. 526. |
نوع المنشور: |
Letter; Comment |
اللغة: |
English |
بيانات الدورية: |
Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication Model: Print Cited Medium: Internet ISSN: 1534-4436 (Electronic) Linking ISSN: 10811206 NLM ISO Abbreviation: Ann Allergy Asthma Immunol Subsets: MEDLINE |
أسماء مطبوعة: |
Original Publication: McLean, VA : American College of Allergy, Asthma, and Immunology |
مواضيع طبية MeSH: |
Connective Tissue Diseases* , Lymphoproliferative Disorders* , Neoplasms*, Child ; Desensitization, Immunologic ; Humans ; Rituximab |
التعليقات: |
Comment on: Ann Allergy Asthma Immunol. 2019 Jul;123(1):11-15. (PMID: 30885801) |
المشرفين على المادة: |
4F4X42SYQ6 (Rituximab) |
تواريخ الأحداث: |
Date Created: 20191103 Date Completed: 20200302 Latest Revision: 20200302 |
رمز التحديث: |
20231215 |
DOI: |
10.1016/j.anai.2019.09.004 |
PMID: |
31676020 |
قاعدة البيانات: |
MEDLINE |